Early access: 15,547 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
H.R. 1768IntroducedHouse · nowSenatePresidentLawIn committee
Sec. 551 · H.R. 1768

Delivery of a controlled substance by a pharmacy to a prescribing practitioner

Division C — Health › Title V — SUPPORT Act Reauthorization › Subtitle D — Miscellaneous matters

Read this section in the full bill →

This section appears in one version only, so there is nothing to compare yet.

Section 309A(a) of the Controlled Substances Act (21 U.S.C. 829a(a)) is amended by striking paragraph (2) and inserting the following: (2) the controlled substance is a drug in schedule III, IV, or V to be administered— (A) by injection or implantation for the purpose of maintenance or detoxification treatment; or (B) subject to a risk evaluation and mitigation strategy pursuant to section 505–1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355–1) that includes elements to assure safe use of the drug described in subsection (f)(3)(E) of such section, including a requirement for post-administration monitoring by a health care provider..